CN101423503A - 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-carbomethoxyl cyclopropane)-1,3-benzopyrene and synthetic method thereof - Google Patents
2-(trans-2,3-dihydro-2-aryl-1-cyano-3-carbomethoxyl cyclopropane)-1,3-benzopyrene and synthetic method thereof Download PDFInfo
- Publication number
- CN101423503A CN101423503A CNA2008102039941A CN200810203994A CN101423503A CN 101423503 A CN101423503 A CN 101423503A CN A2008102039941 A CNA2008102039941 A CN A2008102039941A CN 200810203994 A CN200810203994 A CN 200810203994A CN 101423503 A CN101423503 A CN 101423503A
- Authority
- CN
- China
- Prior art keywords
- benzothiazole
- cyano
- cyclopropane
- trans
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
Abstract
The invention relates to 2-(trans-2, 3-dihydro-2-aryl-1-cyano-3-methoxycarbonyl cyclopropane)-1, 3-benzothiazole and a synthesizing method thereof. The structural formula of the compound is shown as the right. The method is to replace ethylene-1, 3-benzothiazole, triphenylarsine and methyl bromoacetate by 2-cyanoaryl available as a raw material to synthesize the target product by one kettle method. The method has the advantages of simple and convenient operation, higher yield and the like, and provides an effective path for synthesis of natural products.
Description
Technical field
The present invention relates to a kind of 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-methoxycarbonyl cyclopropane)-1,3-benzothiazole and synthetic method thereof.
Background technology
The research of cyclopropanes compound has occupied extremely important status in the research preparation of biological organic synthesis and medicine and agricultural chemicals.Recently, research finds that more and more the cyclopropane groups decorating molecule can improve the pharmacologically active of molecule greatly, and all have the cyclopropane structural unit in a lot of natural compoundss, therefore the research that cyclopropane is introduced on the compound that biology or pharmacologically active are arranged has caused everybody extensive concern.
Heterocyclic system has great importance in the compound molecule that biological and pharmacologically active are arranged, and has had been found that many clinical values that have in the research and development of new drug.Therefore people's a large amount of research now contains the heterocyclic system of cyclopropane, though found many successful synthetic methods, highly-solid selectively synthesizes them efficiently and is still the emphasis of research.
Summary of the invention:
One of purpose of the present invention is to provide a kind of 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-methoxycarbonyl cyclopropane)-1,3-benzothiazole.
Two of purpose of the present invention is to provide the preparation method of this compound.
For achieving the above object, the reaction mechanism that the inventive method adopts is:
Wherein, Ar is 4-CH
3OC
6H
4, 4-CH
3C
6H
4, C
6H
5, 4-FC
6H
4,, 4-ClC
6H
4,, 3-ClC
6H
4, 2-ClC
6H
4,, 3-NO
2C
6H
4, 2,4-CH
3OC
6H
3Or 3,4-CH
3OC
6H
3
According to above-mentioned reaction mechanism, the present invention adopts following technical scheme:
A kind of 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-methoxycarbonyl cyclopropane)-1, the 3-benzothiazole is characterized in that the structural formula of this compound is:
Wherein, Ar is 4-CH
3OC
6H
4, 4-CH
3C
6H
4, C
6H
5, 4-FC
6H
4,, 4-ClC
6H
4,, 3-ClC
6H
4, 2-ClC
6H
4,, 3-NO
2C
6H
4, 2,4-CH
3OC
6H
3Or 3,4-CH
3OC
6H
3
A kind of above-mentioned 2-(trans-2 for preparing, 3-dihydro-2-aryl-1-cyano-3-methoxycarbonyl cyclopropane)-1, the method of 3-benzothiazole, the concrete steps that it is characterized in that this method are: with 2-cyano-aryl substituted ethylene-1, the 3-benzothiazole, triphenylarsine, methyl bromoacetate and sodium bicarbonate are by 1:(0.09~0.11): (1.1~1.3): the mol ratio of (2.9~3.1) is dissolved in the second cyanogen, stirring and refluxing is reacted to 2-cyano-aryl substituted ethylene-1, the 3-benzothiazole reacts completely, remove and desolvate, column chromatography for separation obtains 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-methoxycarbonyl cyclopropane)-1, the 3-benzothiazole; Described 2-cyano-aryl substituted ethylene-1, the structural formula of 3-benzothiazole is:
Wherein, Ar is 4-CH
3OC
6H
4, 4-CH
3C
6H
4, C
6H
5, 4-FC
6H
4,, 4-ClC
6H
4, 3-ClC
6H
4, 2-ClC
6H
4,, 3-NO
2C
6H
4, 2,4-CH
3OC
6H
3Or 3,4-CH
3OC
6H
3
Thinking that theoretically the trans-cyclopropane benzothiazole derivant that the present invention obtains can be used for biological medicine, is the fine bioactive structural unit of a kind of tool.The inventive method method of the present invention is the 2-cyano-aryl substituted ethylene-1 to be easy to get, 3-benzothiazole, triphenylarsine, methyl bromoacetate are raw material, and one kettle way synthesizes target product, have easy and simple to handle, productive rate is synthetic kind of the valid approach that provides of natural product than advantages such as height.
Embodiment
The concrete steps of reaction are: with 2-cyano-aryl substituted ethylene-1,3-benzothiazole, triphenylarsine, methyl bromoacetate and sodium bicarbonate are by 1:(0.09~0.11): (1.1~1.3): the mol ratio of (2.9~3.1) is dissolved in the second cyanogen, stirring and refluxing is reacted to 2-cyano-aryl substituted ethylene-1, the 3-benzothiazole reacts completely, remove and desolvate, column chromatography for separation obtains 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-methoxycarbonyl cyclopropane)-1,3-benzothiazole.
Embodiment one: the raw material 2-cyano-aryl substituted ethylene-1 of employing, and the structural formula of 3-benzothiazole is:
Wherein Ar is 4-CH
3OC
6H
4, the product that obtains is 2-(trans-2,3-dihydro-1-cyano group-3-methoxycarbonyl-2-(4-methoxyphenyl) cyclopropane)-1, the 3-benzothiazole, and its structural formula is:
Molecular formula: C
20H
16N
2O
3S
Molecular weight: 364.0882
Outward appearance: colorless solid
Proton nmr spectra (300MHz, CDCl
3,, interior mark: TMS) δ 3.27 (d, J=8.0Hz, 1H, CH), 3.64 (s, 3H, OCH
3), 3.83 (s, 3H, OCH
3), 4.09 (d .J=8.0Hz, 1H, CH), 7.00 (d, J=8.6Hz, 2H, Ar-H), 7.35 (d, J=8.5Hz, 2H, Ar-H), 7.44-7.50 (dt, J=8.0,8.3Hz, 2H, Ar-H), 7.89 (d, J=7.8Hz, 1H, Ar-H), 8.04 (d, J=8.0Hz, 1H, Ar-H)
Infrared absorption (KBr) cm
-13036,2239,1730,1518.
Mass spectrum m/z:364 (M
+, 16), 305 (100), 306 (22), 261 (15), 278 (10), 290 (10), 290 (9), 289 (9), 274 (8)
Ultimate analysis: C, 65.79; H, 4.43; N, 7.66.
Embodiment two: the raw material 2-cyano-aryl substituted ethylene-1 of employing, and the structural formula of 3-benzothiazole is:
Wherein Ar is 4-CH
3C
6H
4, the product that obtains is 2-(trans-2,3-dihydro-1-cyano group-3-methoxycarbonyl-2-(4-tolyl)-cyclopropane)-1, the 3-benzothiazole, and its structural formula is:
Molecular formula: C
20H
16N
2O
2S
Molecular weight: 348.0932
Outward appearance: colorless solid
Proton nmr spectra (300MHz, CDCl
3,, interior mark: TMS) δ 2.37 (s, 3H, CH
3), 3.30 (d, J=8.0Hz, 1H, CH), 3.64 (s, 3H, OCH
3), 4.10 (d, J=8.0Hz, 1H, CH), 7.24 (d, J=7.6Hz, 2H, Ar-H), 7.32 (d, J=7.9Hz, 2H, Ar-H), 7.41-7.46 (t, J=7.5Hz, 1H, Ar-H), 7.49-7.54 (t, J=7.5Hz, 1H, Ar-H), 7.88 (d, J=7.6Hz, 1H, Ar-H), 8.04 (d, J=7.6Hz, 1H, Ar-H)
Infrared absorption (KBr) cm
-13031,2238,1754,1516.Anal.Calcd.for C
20H
16N
2O
2S:C, 68.95; H, 4.63; N, 8.04.Found:C, 68.93; H, 4.61; N, 8.05.
Mass spectrum m/z:348 (M
+, 12), 289 (100), 290 (21), 262 (20), 274 (15), 288 (6), 291 (6) 127 (5)
Ultimate analysis: C, 68.93; H, 4.61; N, 8.05.
Embodiment three: the raw material 2-cyano-aryl substituted ethylene-1 of employing, and the structural formula of 3-benzothiazole is:
Wherein Ar is C
6H
5, the product that obtains is 2-(trans-2,3-dihydro-1-cyano group-3-methoxycarbonyl-2-benzyl ring propane)-1, the 3-benzothiazole, and its structural formula is:
Molecular formula: C
19H
14N
2O
2S
Molecular weight: 334.0776
Outward appearance: colorless solid
Proton nmr spectra (300MHz, CDCl
3,, interior mark: TMS) δ 3.33 (d, J=8.0Hz, 1H, CH), 3.66 (s, 3H, OCH
3), 4.17 (d, J=8.2Hz, 1H, CH), 7.40-7.55 (m, 7H, Ar-H), 7.90 (d, J=7.7Hz, 1H, Ar-H); 8.06 (d, J=7.8Hz, 1H, Ar-H)
Infrared absorption (KBr) cm
-13030,2240,1746,1513.
Mass spectrum m/z:334 (M
+, 6), 275 (100), 276 (21), 248 (21), 40 (13), 140 (13), 59 (11) 274 (10), 205 (10)
Ultimate analysis: C, 68.25; H, 4.22; N, 8.39.
Embodiment four: the raw material 2-cyano-aryl substituted ethylene-1 of employing, and the structural formula of 3-benzothiazole is:
Wherein Ar is 4-FC
6H
4, the product that obtains is 2-(trans-2,3-dihydro-1-cyano group-2-(4-fluorophenyl)-3-methoxycarbonyl cyclopropane)-1, the 3-benzothiazole, and its structural formula is:
Molecular formula: C
19H
13FN
2O
2S
Molecular weight: 352.0682
Outward appearance: colorless solid
Proton nmr spectra (300MHz, CDCl
3,, interior mark: TMS) δ 3.28 (d, J=8.0Hz, 1H, CH), 3.65 (s, 3H, OCH
3), 4.13 (d, J=8.0Hz, 1H, CH), 7.11-7.16 (t, J=7.1Hz, 2H, Ar-H), and 7.40-7.44 (m, 3H, Ar-H), 747-7.55 (m, 1H, Ar-H), 7.73 (d, J=7.8Hz, 1H, Ar-H), 8.05 (d, J=8.0Hz, 1H, Ar-H) infrared absorption (KBr) cm
-13023,2238,1741,1513.
Mass spectrum m/z:352 (M
+, 7), 293 (100), 294 (21), 266 (15), 158 (11), 290 (10), 292 (8), 295 (6), 146 (5) ultimate analysis: C, 64.70; H, 3.67; N, 7.92.
Embodiment five: the raw material 2-cyano-aryl substituted ethylene-1 of employing, and the structural formula of 3-benzothiazole is:
Wherein Ar is 4-ClC
6H
4, the product that obtains is 2-(trans-2,3-dihydro-2-(4-chloro-phenyl-)-1-cyano group-3-methoxycarbonyl cyclopropane)-1, the 3-benzothiazole, and its structural formula is:
Molecular formula: C
19H
13ClN
2O
2S
Molecular weight: 368.0386
Outward appearance: colorless solid
Proton nmr spectra (300MHz, CDCl
3,, interior mark: TMS) δ 3.27 (d, J=8.0Hz, 1H, CH), 3.65 (s, 3H, OCH
3), 4.13 (d, J=8.0Hz, 1H, CH), 7.36-7.45 (m, 4H, Ar-H), 7.47-7.65 (m, 2H, Ar-H), 7.89 (d, J=8.0Hz, 1H, Ar-H), 8.04 (d, J=8.0Hz, 1H, Ar-H)
Infrared absorption (KBr) cm
-13011,2240,1680,1556.
Mass spectrum m/z:368 (M
+, 16), 309 (100), 311 (38), 274 (37), 310 (22), 273 (12), 275 (8), 312 (7)
Ultimate analysis: C, 61.86; H, 3.56; N, 7.54.
Embodiment six: the raw material 2-cyano-aryl substituted ethylene-1 of employing, and the structural formula of 3-benzothiazole is:
Wherein Ar is 3-ClC
6H
4, the product that obtains is 2-(trans-2,3-dihydro-2-(3-chloro-phenyl-)-1-cyano group-3-methoxycarbonyl cyclopropane)-1, the 3-benzothiazole, and its structure is:
Molecular formula: C
19H
13ClN
2O
2S
Molecular weight: 368.0386
Outward appearance: colorless solid
Proton nmr spectra (300MHz, CDCl
3,, interior mark: TMS) δ 3.31 (d, J=8.0Hz, 1H, CH), 3.65 (s, 3H, OCH
3), 4.13 (d, J=8.0Hz, 1H, CH), 7.33-7.56 (m, 6H, Ar-H), 7.90 (d, J=8.0Hz, 1H, Ar-H), 8.05 (d, J=8.0Hz, 1H, Ar-H)
Infrared absorption (KBr) cm
-13031,2240,1749,1569.
Mass spectrum m/z:368 (M
+, 16), 309 (100), 274 (40), 311 (38), 310 (22), 273 (17), 275 (9), 247 (8) ultimate analysis: C, 61.90; H, 3.50; N, 7.52.
Embodiment seven: the raw material 2-cyano-aryl substituted ethylene-1 of employing, and the structural formula of 3-benzothiazole is:
Wherein Ar is 2-ClC
6H
4, the product that obtains is 2-(trans-2,3-dihydro-2-(2-chloro-phenyl-)-1-cyano group-3-methoxycarbonyl cyclopropane)-1, the 3-benzothiazole, and its structural formula is:
Molecular formula: C
19H
13ClN
2O
2S
Molecular weight: 368.0386
Outward appearance: colorless solid
Proton nmr spectra (300MHz, CDCl
3,, interior mark: TMS) δ 3.34 (d, J=8.0Hz, 1H, CH), 3.69 (s, 3H, OCH
3), 4.11 (d, J=8.0Hz, 1H, CH), 7.33-7.58 (m, 6H, Ar-H), 7.91 (d, J=8.0Hz, 1H, Ar-H), 8.04 (d, J=8.0Hz, 1H, Ar-H)
Infrared absorption (KBr) cm
-13054,2241,1731,1505.
Mass spectrum m/z:368 (M
+, 16), 309 (100), 40 (44), 311 (38), 274 (34), 275 (24), 310 (21), 43 (17), 59 (16)
Ultimate analysis C, 61.92; H, 3.55; N, 7.55.
Embodiment eight: the raw material 2-cyano-aryl substituted ethylene-1 of employing, and the structural formula of 3-benzothiazole is:
Wherein Ar is 3-NO
2C
6H
4, the product that obtains is 2-(trans-2,3-dihydro-1-cyano group-3-methoxycarbonyl-2-(3-nitrophenyl) cyclopropane)-1, the 3-benzothiazole, and its structure is:
Molecular formula: C
19H
13N
3O
4S
Molecular weight: 379.0627
Outward appearance: colorless solid
Proton nmr spectra (300MHz, CDCl
3,, interior mark: TMS) δ 3.39 (d, J=8.0Hz, 1H, CH), 3.67 (s, 3H, OCH
3), 4.29 (d, J=8.0Hz, 1H, CH), 7.44-7.57 (m, 2H, Ar-H), 7.64-7.69 (t, J=8.0Hz, 1H, Ar-H), 7.79-7.82 (d, J=7.7Hz, 1H, Ar-H), 7.81 (d, J=8.0Hz, 1H, Ar-H), 8.06 (d, J=8.0Hz, 1H, Ar-H), 8.27-8.33 (t, J=8.0Hz, 2H, Ar-H)
Infrared absorption (KBr) cm
-13069,2235,1733,1533.
Mass spectrum m/z:379 (M
+, 9), 320 (100), 274 (36), 321 (22), 273 (22), 272 (13), 59 (13) 198 (10)
Ultimate analysis: C, 60.11, H, 3.38, N, 11.07.
Embodiment nine: the raw material 2-cyano-aryl substituted ethylene-1 of employing, and the structural formula of 3-benzothiazole is:
Wherein Ar is 2,4-CH
3OC
6H
3, the product that obtains is 2-(trans-2,3-dihydro-1-cyano group-3-methoxycarbonyl-2-(2, the 4-dimethoxy phenyl) cyclopropane)-1, the 3-benzothiazole, and its structural formula is:
Molecular formula: C
19H
13N
3O
4S
Molecular weight: 394.0987
Outward appearance: colorless solid
Proton nmr spectra (300MHz, CDCl
3,, interior mark: TMS) δ 3.21 (d, J=7.8Hz, 1H, CH), 3.67 (s, 3H, OCH
3), 3.80 (d, J=8.0Hz, 1H, CH), 3.83 (s, 3H, OCH
3), 3.93 (s, 3H, OCH3), 6.50-6.55 (m, 2H, Ar-H), 7.09-7.12 (d, J=8.2n Hz, 1H, Ar-H), 7.41-7.53 (m, 2H, Ar-H), 7.90 (d, J=8.0Hz, 1H, Ar-H), 8.03 (d, J=8.0Hz, 1H, Ar-H)
Infrared absorption (KBr) cm
-13062,2240,1733,1585.
Mass spectrum m/z:205 (100), 40 (97), 335 (74), 43 (45), 309 (27), 275 (24), 41 (22), 176 (19)
Ultimate analysis: 63.71, H, 4.50, N, 7.09.
Embodiment ten: the raw material 2-cyano-aryl substituted ethylene-1 of employing, and the structural formula of 3-benzothiazole is:
Wherein Ar is 3,4-CH
3OC
6H
3, the product that obtains is 2-(trans-2,3-dihydro-1-cyano group-3-methoxycarbonyl-2-(3, the 4-dimethoxy phenyl) cyclopropane)-1, the 3-benzothiazole, and its structural formula is:
Molecular formula: C
19H
13N
3O
4S
Molecular weight: 394.0987
Outward appearance: colorless solid
Proton nmr spectra (300MHz, CDCl
3,, interior mark: TMS) δ 3.29 (d, J=8.0Hz, 1H, CH), 3.67 (s, 3H, OCH
3), 3.91 (s, 3H, OCH
3), 3.94 (s, 3H, OCH
3), 4.10 (d, J=8.0Hz, 1H, CH), 6.90-6.99 (m, 3H, Ar-H), 7.46-7.53 (m, 2H, Ar-H), 7.90 (d, J=7.8Hz, 1H, Ar-H), 8.06 (d, J=8.2Hz, 1H, Ar-H) infrared absorption (KBr) cm
-13035,2238,1738,1520.
Mass spectrum m/z:57 (100), 43 (93), 335 (82), 71 (63), 85 (43), 55 (43), 69 (37), 41 (35)
Ultimate analysis: C, 63.88, H, 4.52, N, 7.00.
Claims (2)
1. a 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-methoxycarbonyl cyclopropane)-1, the 3-benzothiazole is characterized in that the structural formula of this compound is:
Wherein, Ar is 4-CH
3OC
6H
4, 4-CH
3C
6H
4, C
6H
5, 4-FC
6H
4,, 4-ClC
6H
4,, 3-ClC
6H
4, 2-ClC
6H
4,, 3-NO
2C
6H
4, 2,4-CH
3OC
6H
3Or 3,4-CH
3OC
6H
3
2. one kind prepares 2-according to claim 1 (trans-2,3-dihydro-2-aryl-1-cyano-3-methoxycarbonyl cyclopropane)-1, the method of 3-benzothiazole, the concrete steps that it is characterized in that this method are: with 2-cyano-aryl substituted ethylene-1, the 3-benzothiazole, triphenylarsine, methyl bromoacetate and sodium bicarbonate are by 1:(0.09~0.11): (1.1~1.3): the mol ratio of (2.9~3.1) is dissolved in the second cyanogen, stirring and refluxing is reacted to 2-cyano-aryl substituted ethylene-1, the 3-benzothiazole reacts completely, remove and desolvate, column chromatography for separation obtains 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-methoxycarbonyl cyclopropane)-1, the 3-benzothiazole; Described 2-cyano-aryl substituted ethylene-1, the structural formula of 3-benzothiazole is:
Wherein, Ar is 4-CH
3OC
6H
4, 4-CH
3C
6H
4, C
6H
5, 4-FC
6H
4,, 4-ClC
6H
4,, 3-ClC
6H
4, 2-ClC
6H
4,, 3-NO
2C
6H
4, 2,4-CH
3OC
6H
3Or 3,4-CH
3OC
6H
3
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008102039941A CN101423503A (en) | 2008-12-04 | 2008-12-04 | 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-carbomethoxyl cyclopropane)-1,3-benzopyrene and synthetic method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008102039941A CN101423503A (en) | 2008-12-04 | 2008-12-04 | 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-carbomethoxyl cyclopropane)-1,3-benzopyrene and synthetic method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101423503A true CN101423503A (en) | 2009-05-06 |
Family
ID=40614407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008102039941A Pending CN101423503A (en) | 2008-12-04 | 2008-12-04 | 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-carbomethoxyl cyclopropane)-1,3-benzopyrene and synthetic method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101423503A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2491030A1 (en) * | 2009-10-22 | 2012-08-29 | Fibrotech Therapeutics PTY LTD | Fused ring analogues of anti-fibrotic agents |
US9561201B2 (en) | 2006-07-05 | 2017-02-07 | Fibrotech Therapeutics Pty Ltd | Therapeutic compounds |
US11014873B2 (en) | 2017-02-03 | 2021-05-25 | Certa Therapeutics Pty Ltd. | Anti-fibrotic compounds |
-
2008
- 2008-12-04 CN CNA2008102039941A patent/CN101423503A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9561201B2 (en) | 2006-07-05 | 2017-02-07 | Fibrotech Therapeutics Pty Ltd | Therapeutic compounds |
EP2491030A1 (en) * | 2009-10-22 | 2012-08-29 | Fibrotech Therapeutics PTY LTD | Fused ring analogues of anti-fibrotic agents |
EP2491030A4 (en) * | 2009-10-22 | 2013-04-17 | Fibrotech Therapeutics Pty Ltd | Fused ring analogues of anti-fibrotic agents |
US9062076B2 (en) | 2009-10-22 | 2015-06-23 | Fibrotech Therapeutics Pty Ltd | Fused ring analogues of anti-fibrotic agents |
US9951087B2 (en) | 2009-10-22 | 2018-04-24 | Fibrotech Therapeutics Pty Ltd | Fused ring analogues of anti-fibrotic agents |
US11014873B2 (en) | 2017-02-03 | 2021-05-25 | Certa Therapeutics Pty Ltd. | Anti-fibrotic compounds |
US11603349B2 (en) | 2017-02-03 | 2023-03-14 | Certa Therapeutics Pty Ltd | Anti-fibrotic compounds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lampe et al. | Total Synthesis of (−)-and (+)-Balanol1 | |
CN108314658B (en) | A kind of preparation method of polysubstituted oxazole derivatives | |
CN104803903B (en) | A kind of pyrrole derivatives and its synthetic method and application | |
CN104447604B (en) | A kind of synthetic method of chirality quaternary carbon oxazoline ketonic compound | |
Tang et al. | Synthesis of novel β-amino ketones containing ap-aminobenzoic acid moiety and evaluation of their antidiabetic activities | |
Ying et al. | Green and efficient Knoevenagel condensation catalysed by a DBU based ionic liquid in water | |
CN113861137B (en) | Method for synthesizing furan compound by one-step reaction of ketone and alpha chloroketone | |
CN101423503A (en) | 2-(trans-2,3-dihydro-2-aryl-1-cyano-3-carbomethoxyl cyclopropane)-1,3-benzopyrene and synthetic method thereof | |
Verma et al. | Zinc (II)-catalyzed synthesis of secondary amides from Ketones via Beckmann rearrangement using hydroxylamine-O-sulfonic acid in aqueous media | |
Kang et al. | Protecting group-directed annulations of tetra-substituted oxindole olefins and sulfur ylides: regio-and chemoselective synthesis of cyclopropane-and dihydrofuran-fused spirooxindoles | |
CN110041220B (en) | Symmetrical imide compound and synthetic method thereof | |
CN106380440B (en) | A kind of indone simultaneously pyrrole derivatives and its synthetic method and application | |
CN110845466B (en) | Oxacyclonadiene derivatives, pharmaceutical compositions thereof, process for their preparation and their use | |
Urban et al. | Process Research on [(2 S)-(3-Fluorophenyl)-(1 S)-(5-oxotetrahydrofuran-2-yl) ethyl] carbamic Acid tert-Butyl Ester, a Lactone Intermediate for an Aspartyl Protease Inhibitor | |
CN102775367B (en) | Synthetic method of 3,4,5-tri-substituted oxazole-2-one | |
CN104098507A (en) | Oxindole spiro-cyclopropane derivative and synthetic method thereof | |
TWI670255B (en) | Process for the preparation of halo-substituted benzenes | |
Ren et al. | One-pot method for stereoselective cyclopropanation of electron-deficient olefins with methyl bromoacetate and phenacyl bromide in the presence of triphenylarsine | |
CN110698426B (en) | Method for preparing 1, 3-benzothiazole derivative by efficient catalysis of potassium tert-butoxide | |
CN110963981B (en) | Benzothiazole aryl compound derivatives and preparation method thereof | |
Chang et al. | Diethylaminosulfur Trifluoride (DAST)-Mediated Intramolecular Benzannulation of o-Allylchalcones: Synthesis of 3-Fluorotetralins | |
CN113444101A (en) | Cyclopentane chromanone spliced bis-spiro-indene dione oxoindole compound and preparation method and application thereof | |
CN1112347C (en) | 1-trifluoromethyl-2-alkylvinylaniline derivative and its synthesis | |
CN112939903A (en) | Method for preparing furan compound from aryl ketone bromide | |
CN105622544B (en) | A kind of synthetic method of N- sulfonyls -3,4- dihydro -2H-1,4- thiazines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090506 |